Skip to content

Prevalence of hiv-associated neurocognitive disorders (HAND).

Prevalence of hiv-associated neurocognitive disorders (HAND). - hiv-associated neurocognitive disorders

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON35476
Enrollment
225
Registered
2011-11-22
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cerebral dysfunction hiv-associated neurocognitive disorder

Interventions

None listed

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: - diagnosis hiv - 18 years or older - capable of speaking and reading Dutch - adequate sight and hearing ability to join the study;Inclusion criteria controlgroup Diabetes mellitus: - diagnosis DM 2 - 18 years or older - capable of speaking and reading Dutch - adequate sight and hearing ability to join the study - GFR>30;Inclusion criteria controlgroup healthy volunteer: - 18 years or older - capable of speaking and reading Dutch - adequate sight and hearing ability to join the study

Exclusion criteria

Exclusion criteria: Exclusion criteria: - drugs- and/ or alcohol abuses (in the past two years) - Diagnosis of depression (current or last year) - current use of anti-depressive or anti-psychotic medication - history of learning disabilities, dyslexia or mental retardation - history of Cardiac Vascular Attack or neuro-syphilis with sustained brain damage - Vascular diseases (cerebral, cardiac and peripheral) - (pre)terminal kidney failure, defined as GFR

Design outcomes

Primary

MeasureTime frame
Is the prevalence of a positive HAND screening test-outcome with the hiv dementia scale (less than 14 points is a positive outcome), higher in people living with hiv, compared to people living with diabetes mellitus tye 2 or healthy volunteers?

Secondary

MeasureTime frame
Can we identify determinants associated with a positive result on the hiv dementia scale?

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)